The Discounted Cash Flow (DCF) valuation of Vertex Pharmaceuticals Inc (VRTX) is 524.33 USD. With the latest stock price at 491.34 USD, the upside of Vertex Pharmaceuticals Inc based on DCF is 6.7%.
Based on the latest price of 491.34 USD and our DCF valuation, Vertex Pharmaceuticals Inc (VRTX) is a buy. buying Vertex stocks now will result in a potential gain of 6.7%.
| Range | Selected | |
| WACC / Discount Rate | 6.1% - 8.2% | 7.2% |
| Long-term Growth Rate | 3.0% - 5.0% | 4.0% |
| Fair Price | 341.87 - 1,354.96 | 524.33 |
| Upside | -30.4% - 175.8% | 6.7% |